Research:
Omnibiosystem is a start up biotechnology company focused on the development of new
and emerging therapies and treatment modalities for cancer and neuro-degenetarative diseases.
The primary therapeutic areas of interest/research include oncology and immunology. We work
closely with national and international research groups at academic institutions as well as research companies to develop and apply novel bio-therapeutics as well as small molecules.

When needed, we are outsourcing part of our research project to an independent research group.
While working towards our goal of discovering and developing novel small bio-molecule drug
candidates, we are also interested in developing new research technologies and diagnostic kits.
We aspire to commercialize some of our product in the near future.